Skip to main content

Early value dossiers for medical technologies

The essential tool to understand the value proposition for your product and position it well with reimbursement/HTA stakeholders

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Publication Digest: Market access and value-based pricing of digital health applications in Germany

26 Apr 2023

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Gensorowsky et al. reviewed the legal framework and challenges for market access and pricing of digital health applications (DiGA) in German statutory health insurance (SHI) settings. In addition, the authors provided an evidence-based approach to value-based DiGA pricing that considers the positive healthcare effects and approximates the willingness to pay by the sickness funds. The proposed approach can provide objective guidance for price negotiations, although numerous methodological and procedural issues related to DiGA pricing are still unsolved.

Access the full-text article here.